710 related articles for article (PubMed ID: 8839054)
21. Oxidative transformation of 2-hydroxyestrone. Stability and reactivity of 2,3-estrone quinone and its relationship to estrogen carcinogenicity.
Tabakovic K; Gleason WB; Ojala WH; Abul-Hajj YJ
Chem Res Toxicol; 1996; 9(5):860-5. PubMed ID: 8828921
[TBL] [Abstract][Full Text] [Related]
22. Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes.
Bolton JL; Thompson JA
Drug Metab Dispos; 1991; 19(2):467-72. PubMed ID: 1676656
[TBL] [Abstract][Full Text] [Related]
23. Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones.
Stack DE; Li G; Hill A; Hoffman N
Chem Res Toxicol; 2008 Jul; 21(7):1415-25. PubMed ID: 18547067
[TBL] [Abstract][Full Text] [Related]
24. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
Butterworth M; Lau SS; Monks TJ
Drug Metab Dispos; 1996 May; 24(5):588-94. PubMed ID: 8723741
[TBL] [Abstract][Full Text] [Related]
25. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
[TBL] [Abstract][Full Text] [Related]
26. Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts.
Zhuo X; Zhao W; Zheng J; Humphreys WG; Shu YZ; Zhu M
Chem Biol Interact; 2009 Oct; 181(2):227-35. PubMed ID: 19576871
[TBL] [Abstract][Full Text] [Related]
27. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
Dawling S; Hachey DL; Roodi N; Parl FF
Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
[TBL] [Abstract][Full Text] [Related]
28. Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism.
Hachey DL; Dawling S; Roodi N; Parl FF
Cancer Res; 2003 Dec; 63(23):8492-9. PubMed ID: 14679015
[TBL] [Abstract][Full Text] [Related]
29. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
Fan PW; Zhang F; Bolton JL
Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone.
Zhang F; Fan PW; Liu X; Shen L; van Breemen RB; Bolton JL
Chem Res Toxicol; 2000 Jan; 13(1):53-62. PubMed ID: 10649967
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
[TBL] [Abstract][Full Text] [Related]
32. Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites.
Tang W; Stearns RA; Bandiera SM; Zhang Y; Raab C; Braun MP; Dean DC; Pang J; Leung KH; Doss GA; Strauss JR; Kwei GY; Rushmore TH; Chiu SH; Baillie TA
Drug Metab Dispos; 1999 Mar; 27(3):365-72. PubMed ID: 10064567
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and reactivity of the catechol metabolites from the equine estrogen, 8,9-dehydroestrone.
Zhang F; Yao D; Hua Y; van Breemen RB; Bolton JL
Chem Res Toxicol; 2001 Jun; 14(6):754-63. PubMed ID: 11409947
[TBL] [Abstract][Full Text] [Related]
34. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
Saeed M; Gunselman SJ; Higginbotham S; Rogan E; Cavalieri E
Steroids; 2005 Jan; 70(1):37-45. PubMed ID: 15610895
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones.
Yao D; Zhang F; Yu L; Yang Y; van Breemen RB; Bolton JL
Chem Res Toxicol; 2001 Dec; 14(12):1643-53. PubMed ID: 11743747
[TBL] [Abstract][Full Text] [Related]
36. Consequences of quercetin methylation for its covalent glutathione and DNA adduct formation.
van der Woude H; Boersma MG; Alink GM; Vervoort J; Rietjens IM
Chem Biol Interact; 2006 Apr; 160(3):193-203. PubMed ID: 16516181
[TBL] [Abstract][Full Text] [Related]
37. Mutagenic properties of estrogen quinone-derived DNA adducts in simian kidney cells.
Terashima I; Suzuki N; Shibutani S
Biochemistry; 2001 Jan; 40(1):166-72. PubMed ID: 11141067
[TBL] [Abstract][Full Text] [Related]
38. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
[TBL] [Abstract][Full Text] [Related]
39. Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol.
Michalsen BT; Gherezghiher TB; Choi J; Chandrasena RE; Qin Z; Thatcher GR; Bolton JL
Chem Res Toxicol; 2012 Jul; 25(7):1472-83. PubMed ID: 22642258
[TBL] [Abstract][Full Text] [Related]
40. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
